EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HSCs/MPPs as cells of origin with altered differentiation hierarchy impairing immunomicroenvironment in PML::RARA and CBFα/β fusion AML

Niu Qiao, Zi-Xuan Wang, Yu-Liang Zhang, Liu-Qing-Qing Zhang, Hong-Ming Zhu iD, Xiang-Qin Weng iD, Yong-Mei Zhu, Wen-Yan Cheng, Jian-Feng Li iD, Lu Jiang, Xiao-Yu Yan, Guang Yang und 6 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2526334123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Niu Qiao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Research…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Oncogene Proteins, Fusion, Hematopoietic Stem Cells, Neoplastic Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), the Overseas Expertise Introduction Project for Discipline Innovation, Innovative Research Team of High-level Local Universities in Shanghai, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The theoretical possibility for leukemia stem cells (LSCs) to produce both leukemia blasts and dysfunctional immune cells remains underexplored. Here, we investigate three major fusion transcription factor (fTF)-driven acute myeloid leukemia (AML) subtypes [ RUNX1(CBFα)::RUNX1T1 , PML::RARA , and CBFB::MYH11 ] using two optimized single-cell RNA-sequencing technologies to trace fTF expression in 24 de novo AML patients. We demonstrate that the fTFs are widely expressed not only in leukemia blasts but also in differentiated myeloid and lymphoid cells, indicating hematopoietic stem cells or multipotent progenitors (HSCs/MPPs) as LSCs that propagate altered cellular differentiation hierarchies, including immune cells. DNA-FISH confirms the presence of fTFs in T lymphoid and erythroid cells, and targeted sequencing of secondary mutations in sublineages of cells corroborates hierarchical and stepwise leukemogenesis. By tracking RUNX1::RUNX1T1 -expressing cells in patients with or without relapse post–frontline chemotherapy, we highlight the necessity of eradicating LSCs to achieve sustained long-term complete remission and restore a functional immune system capable of suppressing residual disease over time. Comparative single-cell transcriptome analyses further reveal that fTFs are associated with AML subtype-specific differentiation defects in both innate and adaptive immune compartments, suggesting an altered landscape of immune cell–cell communication networks that may facilitate the survival and proliferation of leukemic blasts. Through the examination of intercellular communications among various putative fTF + and normal cell populations, we developed a ligand–receptor (L–R)-based risk-scoring model with independent prognostic value. Collectively, these findings provide insights into the cells of origin of LSCs and the implications of fTF expression for the immune landscape of AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteOncogene Proteins, FusionHematopoietic Stem CellsNeoplastic Stem CellsMultipotent Stem CellsHumansCell DifferentiationTumor MicroenvironmentCore Binding Factor beta Subunit

Stichwörter der Autor:innen

acute myeloid leukemiafusion transcription factorleukemia stem cellsingle-cell RNA sequencingsubtype-specific characteristics

Substanzen

Oncogene Proteins, Fusionpromyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinCore Binding Factor beta Subunit

Autor:innen und Institutionen

  • Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Research Unit of Hematologic Malignancies Genomics and Translational Research…

ORCID-Profile: Hong-Ming Zhu, Xiang-Qin Weng, Jian-Feng Li, Sheng-Yue Wang, Zhu Chen, Xiao-Jian Sun, Sai-Juan Chen

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • the Overseas Expertise Introduction Project for Discipline Innovation
  • Innovative Research Team of High-level Local Universities in Shanghai, CAMS Innovation Fund for Medical Sciences
  • Samuel Waxman Cancer Research Foundation, the National Key Research and Development Program of China
  • the Yangfan Program of the Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Qiao, N., Wang, Z. X., Zhang, Y. L., Zhang, L. Q., Zhu, H. M., Weng, X. Q., Zhu, Y. M., Cheng, W. Y., Li, J. F., Jiang, L., Yan, X. Y., Yang, G., Shen, Y., Wang, S. Y., Chen, Z., Sun, X. J., Liu, F., & Chen, S. J. (2026). HSCs/MPPs as cells of origin with altered differentiation hierarchy impairing immunomicroenvironment in PML::RARA and CBFα/β fusion AML. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2526334123

Vancouver

Qiao N, Wang ZX, Zhang YL, Zhang LQ, Zhu HM, Weng XQ, et al. HSCs/MPPs as cells of origin with altered differentiation hierarchy impairing immunomicroenvironment in PML::RARA and CBFα/β fusion AML. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2526334123

BibTeX
@article{Qiao2026,
  author = {Qiao, Niu and Wang, Zi-Xuan and Zhang, Yu-Liang and Zhang, Liu-Qing-Qing and Zhu, Hong-Ming and Weng, Xiang-Qin and Zhu, Yong-Mei and Cheng, Wen-Yan and Li, Jian-Feng and Jiang, Lu and Yan, Xiao-Yu and Yang, Guang and Shen, Yang and Wang, Sheng-Yue and Chen, Zhu and Sun, Xiao-Jian and Liu, Feng and Chen, Sai-Juan},
  title = {HSCs/MPPs as cells of origin with altered differentiation hierarchy impairing immunomicroenvironment in PML::RARA and CBFα/β fusion AML},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2526334123}
}
Kostenlos starten →